JP2007532134A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007532134A5 JP2007532134A5 JP2007508442A JP2007508442A JP2007532134A5 JP 2007532134 A5 JP2007532134 A5 JP 2007532134A5 JP 2007508442 A JP2007508442 A JP 2007508442A JP 2007508442 A JP2007508442 A JP 2007508442A JP 2007532134 A5 JP2007532134 A5 JP 2007532134A5
- Authority
- JP
- Japan
- Prior art keywords
- vinyl
- ester
- group
- lipase
- rapamycin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 6
- 239000004367 Lipase Substances 0.000 claims 5
- QFJCIRLUMZQUOT-HPLJOQBZSA-N Sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 5
- 108090001060 lipase Proteins 0.000 claims 5
- 102000004882 lipase Human genes 0.000 claims 5
- 235000019421 lipase Nutrition 0.000 claims 5
- 229960002930 sirolimus Drugs 0.000 claims 5
- 229940040461 Lipase Drugs 0.000 claims 4
- 229920001567 Vinyl ester Polymers 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 3
- -1 isopropenyl ester Chemical class 0.000 claims 3
- 241000589513 Burkholderia cepacia Species 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N MeOtBu Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims 2
- 241001661345 Moesziomyces antarcticus Species 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 150000008064 anhydrides Chemical class 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 2
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- PTBDIHRZYDMNKB-UHFFFAOYSA-N 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid Chemical compound OCC(C)(CO)C(O)=O PTBDIHRZYDMNKB-UHFFFAOYSA-N 0.000 claims 1
- IGRURXZWJCSNKU-UHFFFAOYSA-M 3-methylbut-3-enoate Chemical group CC(=C)CC([O-])=O IGRURXZWJCSNKU-UHFFFAOYSA-M 0.000 claims 1
- 241000228245 Aspergillus niger Species 0.000 claims 1
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- 241000222175 Diutina rugosa Species 0.000 claims 1
- 108010084311 Novozyme 435 Proteins 0.000 claims 1
- 241000589540 Pseudomonas fluorescens Species 0.000 claims 1
- 241000235403 Rhizomucor miehei Species 0.000 claims 1
- 241000303962 Rhizopus delemar Species 0.000 claims 1
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 claims 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 1
- 150000008065 acid anhydrides Chemical class 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 230000001580 bacterial Effects 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- LKYXEULZVGJVTG-UHFFFAOYSA-N chloromethane Chemical compound Cl[CH] LKYXEULZVGJVTG-UHFFFAOYSA-N 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- IYNRVIKPUTZSOR-HWKANZROSA-N ethenyl (E)-but-2-enoate Chemical compound C\C=C\C(=O)OC=C IYNRVIKPUTZSOR-HWKANZROSA-N 0.000 claims 1
- XJELOQYISYPGDX-UHFFFAOYSA-N ethenyl 2-chloroacetate Chemical compound ClCC(=O)OC=C XJELOQYISYPGDX-UHFFFAOYSA-N 0.000 claims 1
- HYYACJIUAYQNKQ-UHFFFAOYSA-N ethenyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate Chemical compound OCC(C)(CO)C(=O)OC=C HYYACJIUAYQNKQ-UHFFFAOYSA-N 0.000 claims 1
- CMDXMIHZUJPRHG-UHFFFAOYSA-N ethenyl decanoate Chemical compound CCCCCCCCCC(=O)OC=C CMDXMIHZUJPRHG-UHFFFAOYSA-N 0.000 claims 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 claims 1
- 239000008079 hexane Substances 0.000 claims 1
- 150000002430 hydrocarbons Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- 229960000235 temsirolimus Drugs 0.000 claims 1
- XTXRWKRVRITETP-UHFFFAOYSA-N vinyl acetate Chemical group CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims 1
- KOZCZZVUFDCZGG-UHFFFAOYSA-N vinyl benzoate Chemical compound C=COC(=O)C1=CC=CC=C1 KOZCZZVUFDCZGG-UHFFFAOYSA-N 0.000 claims 1
Claims (15)
- 使用されるリパーゼが、微生物、例えば、アスペルギルス・ニガー(Aspergillus niger)、カンジダ・アンタルクチカ(Candida antarctica)、カンジダ・ルゴサ(Candida rugosa)、ムコール・ミーヘイ(Mucor miehei)、シュードモナス・セパシア(Pseudomonas cepacia)、シュードモナス・フルオレッセンス(Pseudomonas fluorescens)、リゾープス・デレマ(Rhizopus delemar)からの細菌リパーゼである、請求項1に記載の方法。
- 使用されるリパーゼが、B型カンジダ・アンタルクチカ(Candida antarctica type B)からのもの(NOVOZYME 435リパーゼ)またはシュードモナス・セパシア(Pseudomonas cepacia)からのもの(リパーゼPS−C「Aamano」II)である、請求項2に記載の方法。
- 前記アシル供与体が、ビニルエステル、イソプロペニルエステルまたは無水物である、請求項1から3のいずれか一項に記載の方法。
- 前記ビニルエステルが、式CH2=CH−O−COR1(式中、R1は、ヒドロキシル、ハロゲンおよびSHから独立して選択される基で場合によっては置換されている、C1〜C6アルキル、C2〜C6アルケニル、C6〜C14アリール、ベンジルから成る群より選択される)を有する、請求項4に記載の方法。
- 前記ビニルエステルが、ビニルアセテート、ビニルプロピオネート、ビニルクロロアセテート、ビニルクロトネート、ビニルベンゾエートおよびビニルデカノエートから成る群より選択される、請求項5に記載の方法。
- 前記ビニルエステルが、イソプロピリデン保護ビニル3−ヒドロキシ−2−(ヒドロキシメチル)−2−メチルプロピオネートである、請求項4に記載の方法。
- 前記イソプロペニルエステルが、式CH2=C(CH3)−OCOR2(式中、R2は、ヒドロキシル、ハロゲンおよびSHから独立して選択される基で場合によっては置換されている、C1〜C6アルキル、C2〜C6アルケニル、C6〜C14アリール、ベンジルから成る群より選択される)を有する、請求項4に記載の方法。
- 前記イソプロペニルエステルが、イソプロペニルアセテートである、請求項8に記載の方法。
- 前記無水物が、ハロゲンおよびヒドロキシルから独立して選択される基で場合によっては置換されている、C1〜C8直鎖または分枝鎖アルカン酸無水物である、請求項4に記載の方法。
- 前記反応が、トルエン、t−ブチルメチルエーテル(TBME)、エチルエーテル、THF、MeCN、CH2Cl2、CHCl3、ヘキサン、ジオキサンまたはこれらの混合物から成る群より選択される有機溶媒中で行われる、請求項1から10のいずれか一項に記載の方法。
- 前記反応が、20℃から75℃の範囲内で行われる、請求項1から11のいずれか一項に記載の方法。
- CCI−779の前駆体である、イソプロピリデンケタール保護3−ヒドロキシ−2−(ヒドロキシメチル)−2−メチルプロピオン酸とのラパマイシン42−エステルの位置特異的製剤。
- 請求項1から12のいずれか一項に記載の方法に従って製造された位置特異的ラパマイシン42−誘導体を含む組成物もしくは請求項13に記載の位置特異的ラパマイシン42−誘導体製剤を含む組成物、または生理適合性担体をさらに含む該組成物、および該組成物のための容器を含む製品。
- 請求項1から12のいずれか一項に従って製造された位置特異的ラパマイシン42−誘導体の複数の単位を単位剤形で含む薬学的キット。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56192604P | 2004-04-14 | 2004-04-14 | |
PCT/US2005/012266 WO2005105811A1 (en) | 2004-04-14 | 2005-04-12 | Regiospecific synthesis of rapamycin 42-ester derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007532134A JP2007532134A (ja) | 2007-11-15 |
JP2007532134A5 true JP2007532134A5 (ja) | 2008-03-13 |
JP4224115B2 JP4224115B2 (ja) | 2009-02-12 |
Family
ID=34965235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007508442A Expired - Fee Related JP4224115B2 (ja) | 2004-04-14 | 2005-04-12 | ラパマイシン42−エステル誘導体の位置特異的合成 |
Country Status (23)
Country | Link |
---|---|
US (1) | US7268144B2 (ja) |
EP (1) | EP1737869A1 (ja) |
JP (1) | JP4224115B2 (ja) |
KR (1) | KR20070015544A (ja) |
CN (1) | CN1942476A (ja) |
AR (1) | AR049019A1 (ja) |
AU (1) | AU2005238431A1 (ja) |
BR (1) | BRPI0509852A (ja) |
CA (1) | CA2562952A1 (ja) |
CL (1) | CL2008000507A1 (ja) |
CR (1) | CR8646A (ja) |
EC (1) | ECSP066927A (ja) |
GT (1) | GT200500085A (ja) |
IL (1) | IL178315A0 (ja) |
MX (1) | MXPA06011881A (ja) |
NO (1) | NO20065090L (ja) |
PA (1) | PA8629901A1 (ja) |
PE (1) | PE20060253A1 (ja) |
RU (1) | RU2387657C2 (ja) |
SG (1) | SG152234A1 (ja) |
TW (1) | TW200536542A (ja) |
UA (1) | UA87492C2 (ja) |
WO (1) | WO2005105811A1 (ja) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2493878C (en) | 2002-07-30 | 2013-07-23 | Wyeth | Parenteral formulations containing a rapamycin hydroxyester |
WO2005105812A1 (en) * | 2004-04-14 | 2005-11-10 | Wyeth | Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies |
CA2562164A1 (en) * | 2004-04-27 | 2005-11-10 | Wyeth | Labeling of rapamycin using rapamycin-specific methylases |
BRPI0514206A (pt) * | 2004-08-10 | 2008-06-03 | Wyeth Corp | composto, anticorpo, kit para monitorar a terapia com cci-779, e, métodos para detectar metabólitos de cci-779, e para produzir um metabólito sintético e um derivado de cci-779 |
EP1856130A1 (en) * | 2005-02-09 | 2007-11-21 | Wyeth a Corporation of the State of Delaware | Cci-779 polymorph and use thereof |
US7538119B2 (en) * | 2005-11-04 | 2009-05-26 | Wyeth | 41-Methoxy isotope labeled rapamycin 42-ester |
AU2006322030A1 (en) * | 2005-12-07 | 2007-06-14 | Wyeth | Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry |
JP2009518413A (ja) * | 2005-12-07 | 2009-05-07 | ワイス | 精製結晶性cci−779を調製するためのプロセス |
JP2009518412A (ja) * | 2005-12-07 | 2009-05-07 | ワイス | ラパマイシン42−エステルボロネートからラパマイシン42−エステルを調製するためのスケーラブルな方法 |
KR20080106225A (ko) * | 2006-03-07 | 2008-12-04 | 와이어쓰 | 마크롤라이드 면역억제제의 수용성 폴리에틸렌 글리콜 콘쥬게이트를 제조하는 방법 |
US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US20080175887A1 (en) | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
TW200845960A (en) * | 2007-04-05 | 2008-12-01 | Wyeth Corp | Wortmannin-rapalog conjugate and uses thereof |
US20090253733A1 (en) * | 2008-04-02 | 2009-10-08 | Biointeractions, Ltd. | Rapamycin carbonate esters |
US20110098241A1 (en) * | 2008-04-14 | 2011-04-28 | Poniard Pharmaceuticals, Inc. | Rapamycin analogs as anti-cancer agents |
WO2010024898A2 (en) | 2008-08-29 | 2010-03-04 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
CN101676291B (zh) * | 2008-09-18 | 2012-05-09 | 上海海和药物研究开发有限公司 | 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途 |
DK2365802T3 (da) | 2008-11-11 | 2017-11-13 | Univ Texas | Mikrokapsler af rapamycin og anvendelse til behandling af cancer |
IT1394309B1 (it) * | 2009-05-22 | 2012-06-06 | Poli Ind Chimica Spa | Nuovo approccio chimico-enzimatico alla sintesi del pimecrolimus |
US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
BR112013025085A2 (pt) * | 2011-04-01 | 2016-07-19 | Sandoz Ag | processo para a acilação de rapamicina e processo para sintetizar tensirolimo |
CN104203959B (zh) * | 2012-06-08 | 2017-09-15 | 百多力股份公司 | 雷帕霉素40‑o‑环状烃酯、组合物和方法 |
US10751450B2 (en) | 2012-06-08 | 2020-08-25 | Biotronik Ag | Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods |
DK2968281T3 (da) | 2013-03-13 | 2020-11-02 | Univ Texas | Mtor-hæmmere til forebyggelse af vækst af tarmpolyp |
SG11201507406YA (en) | 2013-03-15 | 2015-10-29 | Biosensors Int Group Ltd | Purification of rapamycin derivatives |
US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
CA2933908C (en) | 2013-12-31 | 2024-01-30 | Rapamycin Holdings, Llc | Oral rapamycin nanoparticle preparations and use |
CA3052479A1 (en) | 2017-02-17 | 2018-08-23 | Trevena, Inc. | 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
ES2871499T3 (es) | 2017-05-15 | 2021-10-29 | Bard Inc C R | Dispositivo médico con recubrimiento de elución de fármaco y capa intermedia |
EP3713547A4 (en) * | 2017-11-20 | 2023-07-19 | Icahn School of Medicine at Mount Sinai | TRAINED IMMUNITY INHIBITION USING A THERAPEUTIC BIOLOGICAL NANO-COMPOSITION |
WO2020101675A1 (en) | 2018-11-14 | 2020-05-22 | Lutonix, Inc. | Medical device with drug-eluting coating on modified device surface |
WO2020209828A1 (en) | 2019-04-08 | 2020-10-15 | Bard Peripheral Vascular, Inc. | Medical device with drug-eluting coating on modified device surface |
US20240100025A1 (en) * | 2020-12-14 | 2024-03-28 | Biotronik Ag | Materials and Methods for Treating Viral and Other Medical Conditions |
MX2023011004A (es) | 2021-03-19 | 2024-01-08 | Trained Therapeutix Discovery Inc | Compuestos para regular la inmunidad entrenada y métodos para usarlos. |
WO2023070605A1 (en) * | 2021-10-29 | 2023-05-04 | Trevena, Inc. | Methods of preparing 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds |
CN118027062A (zh) * | 2023-11-03 | 2024-05-14 | 沈阳药科大学 | 一种雷帕霉素前药及其纳米制剂的制备和应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
US4316885A (en) | 1980-08-25 | 1982-02-23 | Ayerst, Mckenna And Harrison, Inc. | Acyl derivatives of rapamycin |
US4650803A (en) | 1985-12-06 | 1987-03-17 | University Of Kansas | Prodrugs of rapamycin |
US5210030A (en) | 1990-06-25 | 1993-05-11 | Merck & Co., Inc. | Process for selectively acylating immunomycin |
PT98990A (pt) | 1990-09-19 | 1992-08-31 | American Home Prod | Processo para a preparacao de esteres de acidos carboxilicos de rapamicina |
US5233036A (en) | 1990-10-16 | 1993-08-03 | American Home Products Corporation | Rapamycin alkoxyesters |
US5100883A (en) | 1991-04-08 | 1992-03-31 | American Home Products Corporation | Fluorinated esters of rapamycin |
US5118678A (en) | 1991-04-17 | 1992-06-02 | American Home Products Corporation | Carbamates of rapamycin |
US5118677A (en) | 1991-05-20 | 1992-06-02 | American Home Products Corporation | Amide esters of rapamycin |
US5260300A (en) | 1992-11-19 | 1993-11-09 | American Home Products Corporation | Rapamycin carbonate esters as immuno-suppressant agents |
US5362718A (en) * | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
US5780462A (en) | 1995-12-27 | 1998-07-14 | American Home Products Corporation | Water soluble rapamycin esters |
US6277983B1 (en) | 2000-09-27 | 2001-08-21 | American Home Products Corporation | Regioselective synthesis of rapamycin derivatives |
TWI256395B (en) * | 1999-09-29 | 2006-06-11 | Wyeth Corp | Regioselective synthesis of rapamycin derivatives |
ES2313983T3 (es) | 2000-09-19 | 2009-03-16 | Wyeth | Esteres hidrosolubles de rapamicina. |
CA2493878C (en) | 2002-07-30 | 2013-07-23 | Wyeth | Parenteral formulations containing a rapamycin hydroxyester |
WO2005016935A2 (en) | 2003-08-07 | 2005-02-24 | Wyeth | Regioselective synthesis of cci-779 |
CA2536775A1 (en) | 2003-09-03 | 2005-03-17 | Wyeth | Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same |
AU2004314213A1 (en) * | 2004-01-08 | 2005-08-04 | Wyeth | Directly compressible pharmaceutical composition for the oral admimistration of CCI-779 |
-
2005
- 2005-04-12 WO PCT/US2005/012266 patent/WO2005105811A1/en active Application Filing
- 2005-04-12 JP JP2007508442A patent/JP4224115B2/ja not_active Expired - Fee Related
- 2005-04-12 US US11/103,799 patent/US7268144B2/en not_active Expired - Fee Related
- 2005-04-12 CA CA002562952A patent/CA2562952A1/en not_active Abandoned
- 2005-04-12 MX MXPA06011881A patent/MXPA06011881A/es active IP Right Grant
- 2005-04-12 CN CNA2005800112769A patent/CN1942476A/zh active Pending
- 2005-04-12 RU RU2006134014/04A patent/RU2387657C2/ru not_active IP Right Cessation
- 2005-04-12 AU AU2005238431A patent/AU2005238431A1/en not_active Abandoned
- 2005-04-12 EP EP05733853A patent/EP1737869A1/en not_active Withdrawn
- 2005-04-12 BR BRPI0509852-1A patent/BRPI0509852A/pt not_active IP Right Cessation
- 2005-04-12 KR KR1020067021378A patent/KR20070015544A/ko not_active Application Discontinuation
- 2005-04-12 SG SG200902515-6A patent/SG152234A1/en unknown
- 2005-04-13 PA PA20058629901A patent/PA8629901A1/es unknown
- 2005-04-13 AR ARP050101447A patent/AR049019A1/es unknown
- 2005-04-13 TW TW094111640A patent/TW200536542A/zh unknown
- 2005-04-13 GT GT200500085A patent/GT200500085A/es unknown
- 2005-04-13 PE PE2005000409A patent/PE20060253A1/es not_active Application Discontinuation
- 2005-12-04 UA UAA200610949A patent/UA87492C2/ru unknown
-
2006
- 2006-09-21 CR CR8646A patent/CR8646A/es not_active Application Discontinuation
- 2006-09-26 IL IL178315A patent/IL178315A0/en unknown
- 2006-10-16 EC EC2006006927A patent/ECSP066927A/es unknown
- 2006-11-03 NO NO20065090A patent/NO20065090L/no not_active Application Discontinuation
-
2008
- 2008-02-19 CL CL200800507A patent/CL2008000507A1/es unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007532134A5 (ja) | ||
RU2006134014A (ru) | Региоспецифический синтез производных 42-эфира рапамицина | |
González-Sabín et al. | Regioselective enzymatic acylation of complex natural products: expanding molecular diversity | |
Nazir et al. | Evaluation of antioxidant and antimicrobial activities of Bergenin and its derivatives obtained by chemoenzymatic synthesis | |
RU2008134369A (ru) | Способы получения водорастворимых конъюгатов полиэтиленгликоля и макролидных иммунодепрессантов | |
Patti et al. | Use of Mucor miehei lipase in the preparation of long chain 3-O-acylcatechins | |
JP2007532655A (ja) | ラパマイシンコンジュゲートおよび抗体のための前駆体である、ジカルボン酸とのラパマイシン42−エステルおよびジカルボン酸とのfk−50632−エステルの調製プロセス | |
Barbayianni et al. | Biocatalyzed Regio‐and Chemoselective Ester Cleavage: Synthesis of Bioactive Molecules | |
Magnusson et al. | Activation of n-3 polyunsaturated fatty acids as oxime esters: a novel approach for their exclusive incorporation into the primary alcoholic positions of the glycerol moiety by lipase | |
Brahmachari | Lipase-catalyzed organic transformations: a recent update | |
JPH069514B2 (ja) | γ―ヒドロキシデカン酸及びγ―デカラクトンの製造方法 | |
Pchelka et al. | Resolution of racemic 1-azido-3-aryloxy-2-propanols by lipase-catalyzed enantioselective acetylation | |
Koszelewski et al. | Synthesis of Enantiomerically Pure 5, 6‐Dihydropyran‐2‐ones via Chemoenzymatic Sequential DKR‐RCM Reaction | |
Mezzetti et al. | Highly enantioselective kinetic resolution of primary alcohols of the type Ph-X-CH (CH3)-CH2OH by Pseudomonas cepacia lipase: effect of acyl chain length and solvent | |
Sebrão et al. | Regioselective acylation of d-ribono-1, 4-lactone catalyzed by lipases | |
JPH1036301A (ja) | 酵素によるアシル化 | |
Santaniello et al. | Lipase-catalyzed deacylation by alcoholysis: a selective, useful transesterification reaction | |
CZ286077B6 (cs) | Enzymatický způsob stereoselektivní přípravy enantiomeru heterobicyklického alkoholu, čistý enantiomer a jeho použití | |
Bisht et al. | Preparative and mechanistic aspects of inter-estification reactions on diols and peracetylated polyphenolic compounds catalysed by lipases | |
Truppo et al. | A novel resolution of a pharmaceutically important bridged bicyclic ketone intermediate via selective enzymatic reduction with a commercially available ketoreductase | |
Vallikivi et al. | Lipase action on some non-triglyceride substrates | |
Wang et al. | A simple procedure for the synthesis of potential 6-azauridine prodrugs by Thermomyces lanuginosus lipase | |
Ciuffreda et al. | Lipase-catalyzed monoprotection of 1, 4-diols in an organic solvent using vinyl benzoate as acyl transfer agent | |
Li et al. | Unexpected reversal of the regioselectivity in Thermomyces lanuginosus lipase-catalyzed acylation of floxuridine | |
Pchelka et al. | Resolution of racemic 3-aryloxy-1-nitrooxypropan-2-ols by lipase-catalyzed enantioselective acetylation |